SCOTTSDALE, AZ--(Marketwire - January 21, 2008) - Medistem Laboratories, Inc. (OTCBB: MDSM) (FRANKFURT: S2U) has filed a patent application covering recent findings documenting the existence of high concentrations of therapeutic anti-inflammatory cells, called T regulatory cells, in fat tissue. The findings, confirmed by Medistem collaborator Dr. Hao Wang at the Lawson Health Research Institute, London, Canada, supports the possibility that the therapeutic effects previously observed by other groups using fat stem cells may be not be strictly due to the stem cells in the fat tissue but to the T regulatory cell population.
